-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Nirav N. Shah, MD1, Fateeha Furqan, MD2, Aniko Szabo, PhD3*, Jessica Neumann2*, Parameswaran Hari, MD, MRCP4, Dina Schneider5*, Bryon Johnson, PhD1, Mehdi Hamadani, MD1 and Timothy S. Fenske, MD2

1Department of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
3Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
4Medical College of Wisconsin, Milwaukee, WI
5A Miltenyi Biotec Company, Lentigen Technology Inc., Gaithersburg, MD

Javier Munoz, MD, MS, MBA1, Patrick M. Reagan, MD2, Andre H. Goy, MD, MS3*, David B. Miklos, MD, PhD4, Dan Zheng, PhD5*, Xiang Fang, PhD5*, Rhine R. Shen, PhD5*, Rubina Siddiqi, PhD, MBA5*, Ioana Kloos, MD, FRCPC5*, Marie José Kersten, MD, PhD6 and Michael Wang, MD7

1Banner MD Anderson Cancer Center, Gilbert, AZ
2University of Rochester School of Medicine, Rochester, NY
3John Theurer Cancer Center, Hackensack, NJ
4Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
5Kite, a Gilead Company, Santa Monica, CA
6on behalf of HOVON/LLPC, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
7University of Texas MD Anderson Cancer Center, Houston, TX

Yuankai Shi1*, Yongping Song, M.D., Ph.D.2*, Mingzhi Zhang, MD, PhD3, Hongmei Jing4, Zhen Wang5*, Zhiming Li6*, Junyuan Qi7*, Fei Li8*, Wenyu Li9, Jianliang Yang1*, Siman Gao10*, Huizi Ma10*, Heming He10*, Qiying Lu10* and Wenzhi Tian10*

1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
2Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
3Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
4Department of Hematology, Peking University Third Hospital, Beijing, China
5Department of Hematology, Linyi Cancer Hospital, Linyi, China
6Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
7State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
8Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
9Department of Lymphoma, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong, China
10ImmuneOnco Biopharmaceuticals(Shanghai) Inc., Shanghai, China

Jacob D. Soumerai, MD1, Masa Lasica2*, Stephen Opat3,4, Chan Y. Cheah5,6,7, Henry Chan8, Emma Verner9,10*, Eva González Barca11*, Alessandra Tedeschi12*, James Hilger13*, Yiqian Fang13*, David Simpson13* and Constantine S. Tam14,15*

1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
2St Vincent’s Hospital Melbourne, Fitzroy, VIC, Australia
3Monash Health, Clayton, VIC, Australia
4Monash University, Clayton, VIC, Australia
5Medical School, University of Western Australia, Crawley, Australia
6Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
7Linear Clinical Research, Nedlands, Australia
8North Shore Hospital, Auckland, New Zealand
9Concord Repatriation General Hospital, Concord, NSW, Australia
10University of Sydney, Sydney, NSW, Australia
11Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de-Barcelona, Barcelona, Spain
12ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
13BeiGene (Shanghai) Co., Ltd., Shanghai, China and BeiGene USA, Inc., San Mateo, CA
14Monash University, Melbourne, VIC, Australia
15Alfred Hospital, Melbourne, VIC, Australia

Juan-Manuel Sancho, MD, PhD1*, Pau Abrisqueta, MD, PhD2*, Abhijeet Kumar, MD3, Raul Cordoba, MD, PhD4, Monica Tani, MD5*, Teng Liu, PhD6*, Erica Rappold, BSN6*, Peter Langmuir, MD6* and Armando Lopez-Guillermo, MD7

1Clinical Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Barcelona, Spain
2Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
3University of Arizona, Tucson, AZ
4Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
5Haematology Unit Santa Maria delle Croci Hospital, Ravenna, Italy
6Incyte Corporation, Wilmington, DE
7Clinic Barcelona, Barcelona, Spain

Sikander Ailawadhi1, Ricardo D Parrondo, MD2, Betsy Laplant, MS3*, Victoria R. Alegria4*, Jamie B Elliott5*, Ashley Zimmerman6*, Keisha Heslop5*, Dustin Chapin7*, Taimur Sher, MD2, Vivek Roy, MD4, Ahsan Rasheed4*, Aneel Paulus, MD1 and Asher Chanan-Khan, MD8

1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
2Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
3Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
5Department of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
6Hematology-Oncology, Mayo Clinic, Jacksonville, FL
7Mayo Clinic, Jacksonville, FL
8Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL

Chakra P Chaulagain, MD, FACP1, Kevin Landau, MD2*, Hong Liang, PhD2* and Chieh-Lin Fu, MD3

1Department of Hematology and Oncology, Cleveland Clinic Florida, Maroone Cancer Center, Weston, FL
2Cleveland Clinic Flroida, Weston, FL
3Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Flroida, Weston, FL

Alba Cabirta1*, Pau Abrisqueta, MD, PhD2*, Víctor Navarro Garcés3*, Marta Canelo-Vilaseca, MD4*, Marina Gomez-Rosa, MD5*, Alberto Lopez García, MD6*, Tomas García, MD, PhD7*, Fatima De la Cruz, MD8*, Juan-Manuel Sancho, MD, PhD9*, Eduardo Rios Herranz, MD10*, Raul Cordoba, MD, PhD11, Angel Serna, MD12*, Moraima Jiménez, MD13*, Sabela Bobillo, MD, PhD1*, Marta Julia, MD1*, Cecilia Carpio, MD14*, Gloria Iacoboni, MD15*, Laura Gallur, MD16*, Josep Castellvi, MD17*, Francesc Bosch, MD, PhD18 and Ana Marin-Niebla, MD, PhD1*

1Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
2Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
3Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
4Hematology Department, Institut Català d’Oncologia-University Hospital Germans Trias i Pujol, Barcelona, Spain
5Hematology Department, University Hospital Ntra. Sra de Valme, Sevilla, Spain
6Fundación Jimenez Díaz University Hospital, Madrid, Spain
7Hospital Arnau de Vilanova, Lleida, Spain
8Hematology Department, University Hospital Virgen del Rocío, Sevilla, Spain
9Clinical Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
10Hospital Universitario Virgen de Valme, Sevilla, Spain
11Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
12Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
13Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
14Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Hospital Universitario Vall d'Hebrón, Barcelona, Spain
15Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, WA, Spain
16Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
17Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Please Select, Spain
18Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Lorenzo Falchi, MD1, Franck Morschhauser, MD, PhD2*, John G. Gribben, MD, DSc, FRCPath3, Huiqiang Huang, MD, PhD4*, Minh Dinh, MD5*, Rebekah Conlon5*, Xiaorong Chen5*, Brian Elliot, MD6* and John F. Seymour, MBBS, PhD, FRACP7

1Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Hematology Department, Lille University Hospital, Lille, France
3Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
4Sun Yat-sen University, Guangzhou, China
5AbbVie, Inc., North Chicago, IL
6Genmab, Princeton, NJ
7Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Australia

Juan Pablo Alderuccio, MD1, Isildinha M Reis, PhD2*, Jean L. Koff, MD, MSc3, Melissa C. Larson, MS4*, Dai Chihara, MD5, Wei Zhao, MD, MS6*, Sara Haddadi7*, Thomas M. Habermann, MD8, Peter Martin, FRCPC, MD, MS9, Jennifer R Chapman-Fredricks, MD10*, Christopher Strouse, MD11, Brad S. Kahl, MD12, Jonathon B. Cohen, MD, MS13, Jonathan W. Friedberg, MD, MMSc14, James R. Cerhan, MD, PhD4, Christopher R. Flowers, MD15 and Izidore S. Lossos, MD16

1Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
2Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
3Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
7Sylvester Comprehensive Cancer Center, Miami
8Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
9Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
10/Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
11Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
12Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
13Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
14James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
15Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
16Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL

Jose Tomas Navarro, MD, PhD1*, Carolina Celades2,3*, Andrea Usas2,3*, Olga García4*, Eva Gonzalez Barca, MD, PhD5*, Fina Climent, PhD6*, Andrea Feu7*, Ana Isabel Jiminez Ubieto, MD, PhD8*, Alba Gutiérrez de la Peña9*, Mariana Bastos-Oreiro, MD, PhD10,11*, Teresa Aldamiz-Echevarría, MD12*, Antonio Gutierrez, MD, PhD13*, Leyre Bento De Miguel14*, Pau Abrisqueta Costa, MD, PhD15*, Carmen Alonso Prieto16*, Christian David Tejada Chaves, MD16*, Enrique M. Ocio17,18, Noemi Fernandez-Escalada, MD19*, Belén Navarro, MD20*, José Miguel Mateos Pérez, MD21*, Andrea Rivero, MD22*, Carlos Fernández De Larrea, MD, PhD23*, Alberto Lopez-Garcia24*, Paola Sandra Villafuerte Gutierrez, MD25*, Sergio Felipe Pinzón26*, Elena Pérez Ceballos27*, Andrés González28*, José Ángel Hernández-Rivas29,30*, Raquel Del Campo31*, Emilia Pardal, MD32*, Ramon Garcia-Sanz33,34, Jordina Rovira Sole35*, Juan-Manuel Sancho, MD, PhD36* and Gustavo Tapia, MD, Prof.37*

1Hematology, Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
2Josep Carreras Leukaemia Research Institute, Lymphoid Neoplasms, Badalona, Spain
3Medicine, Universitat Autònoma de Barcelona, Badalona, Spain
4Hematology Department, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, PETHEMA Group, Barcelona, Spain
5Institut Catalá d’Oncologia Hospitalet, Universitat de Barcelona, Barcelona, Spain
6Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Spain
7Pathology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Hospitales de Llobregat, Spain
8Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
9Hematology, Hospital 12 de Octubre, Madrid, Spain
10Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
11Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain
12Department of Hematology, Hospital Universitario Gregorio Marañón, Instituto de investigación Sanitaria Gregorio Marañón, Madrid, Spain
13Hematology Department, Hospital Universitario Son Dureta, Palma, Spain
14Department of Hematology, Hospital Universitari Son Espases / IdISBa, Palma De Mallorca, Spain
15Department of Hematology, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
16Hematology and Hemotherapy, Hospital Arnau de Vilanova, Valencia, Spain
17University of Cantabria, Santander, Spain
18Hematology, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
19Hospital Universitario Marqués de Valdecilla, Santander, Spain
20Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
21Hematology, Hospital Universitario Puerta de Hierro, Madrid, Spain
22Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain
23Department of Hematology, IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
24Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
25Hematology and hemotherapy department, Hospital Universitario Príncipe de Asturias, Alcala De Henares, Spain
26Hematology, Hospital del Mar, Barcelona, Spain
27Hematology, Hospital Universitario Morales Meseguer, Murcia, Spain
28Systemic Autoimmune Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain
29Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
30Medicine Department, Universidad Complutense de Madrid, Madrid, Spain
31Hematology Department, Hospital Son Llàtzer, Palma, Spain
32Hematology and Hemotherapy, Hospital Virgen del Puerto, Plasencia, Spain
33Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
34Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
35Institut Catala d’Oncologia. Hospital Joan XXIII, Tarragona, AL, ESP
36Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
37Department of Pathology, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Badalona, Spain

Ilja Kalashnikov, MD1*, Tomas Tanskanen, MD, PhD2*, Leevi Viisanen, MD1*, Nea Malila, MD, PhD2*, Sirkku Jyrkkio, MD, PhD3* and Sirpa Leppä, MD, PhD1

1University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland
3Turku University Hospital, Turku, Finland

Teresa Villalobos, MD1*, Ana Muntañola Prat, MD2*, Sonia González de Villambrosia, MD3*, Maria J. Rodriguez-Salazar, MD4*, Ana Isabel Jiminez Ubieto, MD, PhD5*, Gabriela Bastidas-Mora6*, Raul Cordoba, MD, PhD7, Maria Stefania Infante8*, Maria Jesus Vidal, MD9*, Francisco Javier Diaz-Galvez10*, Monica Baile11*, Mariana Bastos-Oreiro, MD, PhD12,13*, Carlos Panizo14*, Juan-Manuel Sancho, MD, PhD15*, Belen Navarro Matilla16*, Tomas García, MD, PhD17*, Lourdes Escoda, MD18*, Pau Abrisqueta, MD, PhD19*, María José Terol, MD PhD20*, Raquel Del Campo21*, Armando López-Guillermo, MD, PhD22*, Antonio Salar23* and Carlos Montalban, MD, PhD24*

1Hematology, Hospital Universitari Mutua Terrassa, Terrassa, Spain
2Hospital Universitari Mutua Terrassa, Barcelona, Spain
3Hospital Universitario Marqués de Valdecilla, Santander, Spain
4Hematology Department, Hospital General Universitario de Canarias, Santa Cruz de Tenerife, Spain
5Hospital 12 de Octubre, Madrid, Spain
6Hospital Sagrat Cor, Barcelona, Spain
7Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain
8Hospital Infanta Leonor, Madrid, Spain
9Department of Hematology, Hospital Universitario de Leon, Leon, Spain
10Hospital Universitario de Burgos, Burgos, Spain
11Complejo Asistencial Universitario de Salamanca/IBSAL, Salamanca, Spain
12Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
13Hospital General Universitario Gregorio Marañón (IiSGM), Madrid, Spain
14Clínica Universidad de Navarra, Pamplona, Spain
15Hematology Department, ICO-IJC Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
16Hospital Puerta de Hierro, Madrid, Spain
17Hospital Arnau de Vilanova, Lleida, Spain
18Hematology Department, ICO - Hospital Joan XXIII, Tarragona, Spain
19Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, Spain
20Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, Spain
21Hematology Department, Hospital Son Llàtzer, Palma, Spain
22Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain
23Hospital del Mar, Barcelona, Spain
24Hematology, MD Anderson Cancer Center, Madrid, Spain

Angel Serna, MD1*, Angela Sanchez1*, Laia Lopez2*, Juan-Manuel Sancho, MD, PhD3*, Eva Gonzalez Barca, MD, PhD4*, Alberto Lopez-Garcia5*, Raul Cordoba, MD, PhD6, Adolfo Jesús Sáez Marín, MD7*, Ana Isabel Jiminez Ubieto, MD, PhD8*, Ainara Ferrero9*, Tomas García, MD, PhD10*, Alba Cabirta1*, M Moraima Jimenez, MD11*, Lucia Martin, MD11*, Marta Julia, MD11*, Sabela Bobillo, MD, PhD11*, Ana Marin-Niebla, MD, PhD11*, Francesc Bosch, MD, PhD12 and Pau Abrisqueta, MD, PhD13*

1Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
2Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Spain, Barcelona, Spain
3Hematology Department, ICO-IJC Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
4Department of Hematology, Institut Catalá d’Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
5Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
6Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain
7Servicio de Hematología, Hospital 12 de Octubre, Madrid, Madrid, Spain
8Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Hospital Universitario 12 de Octubre, Complutense University, CNIO, Madrid, MADRID, Spain
9Hematology Department, University Hospital Arnau de Vilanova, Lleida, Lleida, Spain
10Hospital Arnau de Vilanova, Lleida, Spain
11Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
12Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
13Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, Spain

Zheng Weiwei1*, Zhou Hui2*, Xi Zhang, M.D., Ph.D.3*, Jing Hongmei4*, Zhou Dongmei5*, Zhou Fang2*, Gao Li6*, Wan Wei7*, Song Yaobo5*, Haung Yan, PhD8*, Xu Linfeng9*, Hu Yonghan9*, Le Meijie9*, Qi Junyuan1* and Lugui Qiu10

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China, tianjin, China
2Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China, changsha, China
3Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
4Peking University Third Hospital, Beijing, China
5Department of Medical Oncology Ward, Yantaishan Hospital, Yantai, China, yantai, China
6Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China, chongqing, China
7Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China
8Evopoint Biosciences Co., Ltd., Suzhou, China, Shanghai, AL, China
9Evopoint Biosciences Co., Ltd., Suzhou, China, suzhou, China
10State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Qingqing Cai, PhD1, Yi Xia, MD, PhD2*, Panpan Liu, MD, PhD1*, Yuchen Zhang, BMBS1*, Huiqiang Huang, MD, PhD2, Yan Gao3*, Guowei Li, MD, PhD4*, Xiuhua Sun, MD, PhD5* and Xueyi Pan, MD, PhD6*

1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
2Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
3Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, NY, China
4Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, China
5Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, China
6Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

Mayur Narkhede, MBBS1,2, Lauren Shea3*, Gaurav Goyal, MD1 and Amitkumar Mehta, MD1

1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL
3University of Alabama At Birmingham, Birmingham, AL

Nilesh Kapoor, BA1, Qiuhong Zhao, MS2*, Andrew Stiff, MD, PhD2, Seema A. Bhat, MD2, Mirela Iulia Anghelina, MD, MPH2*, Jasmine Neal, MPH2*, Leslie A. Andritsos, MD3, James S. Blachly, MD2, Narendranath Epperla, MD, MS2, Zeinab El Boghdadly, MBBCh4*, Michael R. Grever, MD2 and Kerry A. Rogers, MD2

1College of Medicine, The Ohio State University, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
4Division of Infectious Disease, Department of Internal Medicine, The Ohio State University, Columbus, OH

Karan Chohan1*, Saurabh Zanwar2, Ronald Go, MD2, Jonas Paludo, MD2, Carrie A. Thompson, MD2, Asher Chanan-Khan, MD3, Sikander Ailawadhi3, Thomas M. Habermann, MD2, Thomas E. Witzig, MD2, Morie A Gertz, MD2, Stephen M. Ansell, MD, PhD2, Shaji K Kumar, MD2, Rajiv K. Pruthi, M.B.B.S2, William L. Nichols, MD2, Prashant Kapoor, MD2, Meera Sridharan, MD, PhD2 and Jithma P. Abeykoon, MD2

1Department of Medicine, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Jacksonville, FL

Farheen Mir, MBBS FRCPath1*, Anna Robinson, MBBS2*, Mark Edward Ethell, MD3*, Michael Potter, MD4, Emma Nicholson, MD, PhD5*, Chloe Anthias2*, Sandra Easdale2*, Carlos Gonzalez-Arias2*, Amit Sud, MD, PhD, FRCPath, MRCP2, Claire E. Dearden, MD, FRCP, FRCPath6*, Ian Chau, MD7*, David Cunningham, MD, FRCP, FMedSci8*, Dima El-Sharkawi, MBBS, FRCPath, PhD9*, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR7* and Sunil Iyengar10*

1Royal Marsden Hospital, Sutton, ENG, GBR
2Royal Marsden Hospital, Sutton, United Kingdom
3Royal Marsden Hospital, Sutton, ENG, United Kingdom
4Royal Marsden Hospital, Sutton, GBR
5The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
6Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, United Kingdom
7The Royal Marsden NHS Foundation Trust, London, United Kingdom
8Royal Marsden Hospital, NHS Foundation Trust, London, United Kingdom
9The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom
10Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom

Michael L. Wang, MD1, Nirav N. Shah, MD2, Wojciech Jurczak, MD, PhD3*, Pier Luigi Zinzani, MD, PhD4, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD5*, Chan Yoon Y. Cheah, MD6, Chaitra S. Ujjani, MD7, Youngil Koh, MD, PhD8, Koji Izutsu9*, James N. Gerson, MD10, Ian W. Flinn, MD PhD11, Benoit Tessoulin, MD12*, Alvaro J. Alencar, MD13, Shuo Ma, MD14, Ewa Lech-Marańda, MD, PhD15*, Joanna M. Rhodes, MD, MSCE16, Krish Patel, MD17, Jennifer A. Woyach, MD18, Nicole Lamanna, MD19, Yucai Wang, MD, PhD20, Constantine S. Tam21*, John F. Seymour, MBBS, PhD, FRACP21, Talha Munir, MBBS, MRCP, FRCPath, PhD22*, Hirokazu Nagai, MD, PhD23, Francisco Hernandez-Ilizaliturri, MD24, Anita Kumar, MD25, Andrew D. Zelenetz, MD, PhD25, Preetesh Jain, MBBS, MD, DM, PhD26, Binoj Nair, PhD27*, Donald E. Tsai, MD, PhD27*, Minna Balbas, PhD27*, Richard A. Walgren, MD, PhD27, Paolo B. Abada, MD, PhD27*, Chunxiao Wang, PhD28*, Junjie Zhao, PhD27* and Anthony R. Mato, MD, MSCE25

1MD Anderson Cancer Center, Houston, TX
2Medical College of Wisconsin, Brookfield, WI
3Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
4Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
5Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
6Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia
7Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
8Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
9National Cancer Center Hospital, Tokyo, Japan
10Lymphoma Program, Abramson Cancer Center, Philadelphia, PA
11Sarah Cannon Research Institute, Nashville, TN
12Hematology Department, Nantes University Hospital, Nantes, France
13Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
14Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
15Institute of Hematology and Transfusion Medicine, Warsaw, Poland
16Northwell Health Cancer Institute, New Hyde Park, NY
17Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
18The Ohio State University Comprehensive Cancer Center, Columbus, OH
19New York-Presbyterian/ Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY
20Division of Hematology, Mayo Clinic, Rochester, MN
21Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
22Department of Haematology, St James’s University Hospital, Leeds, United Kingdom
23Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
24Roswell Park Cancer Institute, Buffalo, NY
25Memorial Sloan Kettering Cancer Center, New York, NY
26Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
27Loxo@Lilly, Indianapolis, IN
28Eli Lilly and Company, Indianapolis, IN

Irl Brian Greenwell, MD1, Jeffrey M. Switchenko, PhD, MS2*, Alexander F. M. Craig, MD, MPhil3, Ash A. Alizadeh, MD, PhD4, Pamela B. Allen, MD5, Alicia Escobar6*, Kelly Valla, PharmD7*, Aseala Abousaud, PharmD8*, Priya Parikh6*, Danielle Roberts, PA-C9*, Jessica J. Neely, PA-C6*, Alexandra Palmer, NP-C10*, Kristie A. Blum, MD9, Jonathon B. Cohen, MD, MS11 and Marcela Algave12*

1Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
2Departments of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA
3Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
4Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA
5Department of Hematology, Emory University School of Medicine, Decatur, GA
6Emory University, Atlanta, GA
7Winship Cancer Institute, Emory University Hospital, Atlanta, GA
8Emory Healthcare, Atlanta, GA
9Winship Cancer Institute, Emory University, Atlanta, GA
10Winship Cancer Institute, Emroy University, Atlanta, GA
11Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
12Emory University, Atlanta

Francesca Cordero1*, Simone Ferrero, MD2,3, Simone Pernice1*, Elisa Genuardi3*, Roberta Sirovich4*, Beatrice Alessandria3*, Andrea Evangelista5*, Simone Ragaini2,3*, Maurizio Martelli, MD6*, Alice Di Rocco, MD6*, Alessandro Re, MD7*, Chiara Pagani, MD8*, Vittorio Stefoni, MD9*, Federica Cavallo, MD2,3*, Carola Boccomini10*, Monica Balzarotti, MD11*, Vittorio Ruggero Zilioli, MD12*, Maria Gomes da Silva13*, Luca Arcaini14*, Melania Celli15*, Gian Maria Zaccaria16*, Dora Tortarolo1*, Sergio Cortelazzo17* and Marco Ladetto18

1Department of Computer Science, University of Torino, Torino, Italy
2Division of Hematology , AOU Città della Salute e della Scienza di Torino, Torino, Italy
3Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
4Department of Mathematics G. Peano, University of Torino, Torino, Italy
5Unit of Cancer Epidemiology, CPO Piemonte, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
6Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
7Hematology Division, ASST-Spedali Civili di Brescia, Brescia, Italy
8Department of Hematology, ASST Spedali Civili, Brescia, Italy
9Hematology, Department of Translational and Precision Medicine, Università di Bologna, Bologna, Italy
10Division of Hematology 2, AOU Città della Salute e della Scienza di Torino, Torino, Italy
11Unit of Hematology, Humanitas Clinical and Research Center, Rozzano, Italy
12Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
13Division of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
14Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
15U.O. di Ematologia, Ospedale degli Infermi di Rimini, Rimini, Italy
16Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
17Oncology unit, Clinica Humanitas/Gavazzeni, Bergamo, Italy
18Division of Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Sheila K Pierson, MSc1*, Mateo Sarmiento Bustamante1*, Joshua D Brandstadter, MD, PhD, MSc2, Daisy Alapat3*, Adam Bagg, MD4, Mary Jo Lechowicz, MD5, Gordan Srkalovic, MD, PhD6, Megan S. Lim, MD, PhD7, Frits van Rhee8 and David C Fajgenbaum, MD, MBA, MSc1

1Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, SWARTHMORE, PA
3UAMS, Little Rock, AR
4Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
5Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
6Sparrow Herbert-Herman Cancer Center, Lansing, MI
7Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
8Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR

Robert Stuver, MD1, Esther Drill, DrPH2*, David Qualls, MD3, Michelle Okwali, MPH1*, Connie Lee Batlevi, MD, PhD4, Philip C Caron, MD, PhD1, Zachary D. Epstein-Peterson, MD1, Lorenzo Falchi, MD1, Audrey Hamilton, MD1*, Paul A. Hamlin, MD1, Steven M. Horwitz, MD1, Andrew M. Intlekofer, MD, DPhil1, William T. Johnson, DO1, Niloufer Khan, MD1, Oscar B Lahoud, MD5, Jennifer Kimberly Lue, MD1, Matthew J. Matasar, MD, MS6, Alison J. Moskowitz, MD1, Ariela Noy, MD1, M.Lia Palomba, MD7, Santosha Vardhana, MD, PhD1, Andrew D. Zelenetz, MD, PhD1, Gilles Salles, MD, PhD1 and David J. Straus, MD1

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, Brookline, MA
4Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
5Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY
7Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Neil L Berinstein, MD1, Gail Klein, MSc2*, Katerina Welsh3*, Rebecca McClure, MD4, Nicholas Allen Forward, MD, MSc, FRCPC5, Mona Shafey, MD6, Anna Nikonova, MD7, David MacDonald, MD8, Diego Villa, MD9, Irwindeep Sandhu10*, Mohammed A Aljama, MBBS, FRCPC11 and Jean-François Larouche, MD12

1Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, CAN
2Centre for Clinical Trial Support, Sunnybrook Research Institute, Toronto, ON, Canada
3Sunnybrook Research Institute, Toronto, ON, Canada
4Health Sciences North, Sudbury, ON, Canada
5Hematology, Nova Scotia Health Authority/ Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
6Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
7McGill University Health Centre, Montreal, QC, Canada
8The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
9British Columbia Cancer Agency, Vancouver, BC, Canada
10Cross Cancer Centre, Edmonton, AB, Canada
11Division of Hematology, Juravinski Cancer Centre, Hamilton, ON, Canada
12CHU de Québec – university Laval, Québec, QC, Canada

Tareq Abuasab, MD1, Fadi Haddad, MD1*, Shehab Fareed Mohamed, MD1*, Jeffrey L. Jorgensen, MD, PhD2*, Sa A Wang, MD2*, Philip A. Thompson, MBBS1, Tapan M. Kadia, MD1, Yesid Alvarado, MD1, Sherry A. Pierce, BSN, BA1*, Michael J. Keating, MBBS3, David McCue4*, Hagop Kantarjian, MD5 and Farhad Ravandi, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4UT MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH